Health Care [ 6/12 ] | Biotechnology [ 32/73 ]
NASDAQ | Common Stock
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 25, 24 | 0.00 Increased by +100.00% | - |
| Oct 31, 22 | -0.30 Decreased by -492.89% | - |
| Jun 2, 22 | -0.29 Decreased by -1.64 K% | - |
| Oct 29, 21 | -0.11 Decreased by -558.68% | - |
| Apr 26, 21 | -33.38 Decreased by -129.78 K% | - |
| Mar 31, 21 | -0.05 Decreased by -96.89% | - |
| Dec 31, 20 | -0.02 Decreased by -12.08% | - |
| Sep 30, 20 | -0.02 Decreased by -12.08% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | N/A Decreased by N/A% | -1.85 M Decreased by -179.29 K% | - - |
| Sep 30, 24 | N/A Decreased by N/A% | -2.24 M Decreased by -168.99 K% | - - |
| Mar 31, 24 | N/A Decreased by N/A% | -1.12 K Increased by +99.97% | - - |
| Dec 31, 23 | N/A Increased by +100.00% | -1.03 K Increased by +35.97% | - - |
| Sep 30, 23 | N/A Decreased by N/A% | -1.03 K Decreased by N/A% | - - |
| Mar 31, 23 | N/A Decreased by N/A% | -1.32 K Increased by +31.41% | - - |
| Dec 31, 22 | N/A Decreased by N/A% | -3.23 M Increased by +11.79% | - - |
| Sep 30, 22 | -2.34 B Increased by 0.00% | -1.61 K Increased by +10.14% | Increased by +0.00% Decreased by -10.14% |